142 related articles for article (PubMed ID: 29476987)
1. Isoprenoids and tau pathology in sporadic Alzheimer's disease.
Pelleieux S; Picard C; Lamarre-Théroux L; Dea D; Leduc V; Tsantrizos YS; Poirier J
Neurobiol Aging; 2018 May; 65():132-139. PubMed ID: 29476987
[TBL] [Abstract][Full Text] [Related]
2. Isoprenoids, small GTPases and Alzheimer's disease.
Hooff GP; Wood WG; Müller WE; Eckert GP
Biochim Biophys Acta; 2010 Aug; 1801(8):896-905. PubMed ID: 20382260
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of farnesyl pyrophosphate (FPP) and/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers.
Waller DD; Park J; Tsantrizos YS
Crit Rev Biochem Mol Biol; 2019 Feb; 54(1):41-60. PubMed ID: 30773935
[TBL] [Abstract][Full Text] [Related]
4. Key Enzymes for the Mevalonate Pathway in the Cardiovascular System.
Zhang C; Jin DD; Wang XY; Lou L; Yang J
J Cardiovasc Pharmacol; 2021 Feb; 77(2):142-152. PubMed ID: 33538531
[TBL] [Abstract][Full Text] [Related]
5. Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.
Koppel J; Acker C; Davies P; Lopez OL; Jimenez H; Azose M; Greenwald BS; Murray PS; Kirkwood CM; Kofler J; Sweet RA
Neurobiol Aging; 2014 Sep; 35(9):2021-8. PubMed ID: 24731519
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients.
Eckert GP; Hooff GP; Strandjord DM; Igbavboa U; Volmer DA; Müller WE; Wood WG
Neurobiol Dis; 2009 Aug; 35(2):251-7. PubMed ID: 19464372
[TBL] [Abstract][Full Text] [Related]
7. The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
Dugger BN; Whiteside CM; Maarouf CL; Walker DG; Beach TG; Sue LI; Garcia A; Dunckley T; Meechoovet B; Reiman EM; Roher AE
J Alzheimers Dis; 2016; 51(2):345-56. PubMed ID: 26890756
[TBL] [Abstract][Full Text] [Related]
8. Brain isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate are increased in aged mice.
Hooff GP; Wood WG; Kim JH; Igbavboa U; Ong WY; Muller WE; Eckert GP
Mol Neurobiol; 2012 Aug; 46(1):179-85. PubMed ID: 22692983
[TBL] [Abstract][Full Text] [Related]
9. Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.
Leduc V; Théroux L; Dea D; Dufour R; Poirier J
J Mol Neurosci; 2016 Jan; 58(1):109-19. PubMed ID: 26541602
[TBL] [Abstract][Full Text] [Related]
10. Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.
Jeong A; Suazo KF; Wood WG; Distefano MD; Li L
Crit Rev Biochem Mol Biol; 2018 Jun; 53(3):279-310. PubMed ID: 29718780
[TBL] [Abstract][Full Text] [Related]
11. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
[TBL] [Abstract][Full Text] [Related]
12. Isoprenoids influence expression of Ras and Ras-related proteins.
Holstein SA; Wohlford-Lenane CL; Hohl RJ
Biochemistry; 2002 Nov; 41(46):13698-704. PubMed ID: 12427032
[TBL] [Abstract][Full Text] [Related]
13. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
Weivoda MM; Hohl RJ
Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
[TBL] [Abstract][Full Text] [Related]
14. Altered distribution of RhoA in Alzheimer's disease and AbetaPP overexpressing mice.
Huesa G; Baltrons MA; Gómez-Ramos P; Morán A; García A; Hidalgo J; Francés S; Santpere G; Ferrer I; Galea E
J Alzheimers Dis; 2010; 19(1):37-56. PubMed ID: 20061625
[TBL] [Abstract][Full Text] [Related]
15. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate in neuroblastoma SH-SY5Y-APP695 cells: impact on amyloid beta-protein production.
Hooff GP; Peters I; Wood WG; Müller WE; Eckert GP
Mol Neurobiol; 2010 Jun; 41(2-3):341-50. PubMed ID: 20405344
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
18. Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology.
Wiersma VI; van Hecke W; Scheper W; van Osch MA; Hermsen WJ; Rozemuller AJ; Hoozemans JJ
Acta Neuropathol Commun; 2016 Oct; 4(1):113. PubMed ID: 27793194
[TBL] [Abstract][Full Text] [Related]
19. Feedback inhibition of polyisoprenyl pyrophosphate synthesis from mevalonate in vitro. Implications for protein prenylation.
Lutz RJ; McLain TM; Sinensky M
J Biol Chem; 1992 Apr; 267(12):7983-6. PubMed ID: 1569056
[TBL] [Abstract][Full Text] [Related]
20. [Neurofibrillary changes and phosphorylated tau of Alzheimer's disease].
Takeda M; Kudo T; Taniguchi N; Nishimura T
Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):169-72. PubMed ID: 8648891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
